Renal expression of IGF I in hypersomatotropic states

Am J Physiol. 1990 Aug;259(2 Pt 2):F251-7. doi: 10.1152/ajprenal.1990.259.2.F251.

Abstract

We examined insulin-like growth factor I (IGF I) gene expression in kidney in two models of hypersomatotropism, rats implanted with GH3 pituitary tumors, and rats administered exogenous growth hormone (GH). Both GH3 tumor-bearing rats and rats administered GH gained weight more rapidly than control animals, and had kidneys that were larger than those of controls. Tumor-bearing rats had increased levels of circulating IGF I. Glomeruli from tumor-implanted rats were sclerotic. Immunostainable IGF I was increased in medullary collecting ducts from tumor-bearing and GH-injected rats compared with kidneys from control animals. Levels of IGF I mRNA in kidneys of rats implanted with GH3 tumors and GH-injected rats were elevated compared with levels in kidneys from controls. Our findings demonstrate enhanced renal IGF I gene expression in hypersomatotropism. Stimulation of renal IGF I synthesis by GH could be causative of changes in renal function and renal size that occur in states of GH excess such as acromegaly.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Female
  • Growth Hormone / metabolism
  • Growth Hormone / pharmacology*
  • Immunohistochemistry / methods
  • Insulin-Like Growth Factor I / genetics*
  • Kidney / pathology
  • Kidney / physiology*
  • Kidney / physiopathology
  • Pituitary Neoplasms / genetics
  • Pituitary Neoplasms / metabolism*
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Inbred WF
  • Somatomedins / genetics*
  • Staining and Labeling

Substances

  • RNA, Messenger
  • Somatomedins
  • Insulin-Like Growth Factor I
  • Growth Hormone